Hagan; James Joseph
Patent Applications and Registrations
Patent applications and USPTO patent grants for Hagan; James Joseph.The latest application filed is for "combination of sabcomeline with a neuroleptic agent to treat psychotic disorders".
- Hagan; James Joseph - Essex GB
- Hagan; James Joseph - Herts GB
| Patent | Date |
|---|---|
| Combination Of Sabcomeline With A Neuroleptic Agent To Treat Psychotic Disorders App 20090281078 - ROUTLEDGE; Carol ; et al. | 2009-11-12 |
| Sabcomeline Alone or Combined with a Mood Stabilising or Antimanic Agent to Treat Bipolar Disorders App 20080306043 - Routledge; Carol ; et al. | 2008-12-11 |
| Combination of Sabcomeline with a Neuroleptic Agent to Treat Psychotic Disorders App 20080081804 - Routledge; Carol ; et al. | 2008-04-03 |
| Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72 Grant 6,664,229 - Hagan , et al. December 16, 2 | 2003-12-16 |
| Methods For Treatment Using Novel Ligands Of The Neuropeptide Receptor Hfgan72 App 20030087801 - HAGAN, JAMES JOSEPH ; et al. | 2003-05-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 